



What was known before? 
• Worldwide childhood blindness is a major cause of needless lifelong morbidity particularly in 
low and middle income countries (LMICs) 
• The Red reflex test is a highly sensitive yet simple means to detect congenital cataract the 
main cause of treatable childhood blindness in LMICs 
• The Red reflex is assessed using a traditional direct ophthalmoscope (TDO) 
• TDOs are expensive to purchase and maintain and are consequently rarely used by health 
care workers in LMICs  
What this study adds? 
• The diagnostic performance of a new low cost solar powered direct ophthalmoscope 
(Arclight) is equivalent to that of a more expensive TDO in detecting abnormal red reflexes in 
simulated eyes 
• The majority of Malawian health care workers preferred the Arclight over the TDO  
• The additional features of such a frugal, consumable independent, solar powered and 
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We compared the diagnostic performance and ease of use of a new solar powered low-cost Arclight 
ophthalmoscope (AO) to a more expensive traditional direct ophthalmoscope (TDO) (Keeler 
Professional V.2.8) in detecting abnormal red reflexes in simulated eyes.  
Both devices were used by 19 optometry students and 17 paediatric doctors based in the Kamuzu 
Central Hospital Campus in Lilongwe, Malawi. Participants examined 4 normal and 4 abnormal red 
reflexes using the two devices in random order. We scored the participants on their ability to 
identify clinical signs and make a diagnosis. Participants scored each device for “ease of use”. 
There was no statistically significant difference in diagnostic performance or “ease of use” between 
the AO and the TDO when attempting to detect abnormal red reflexes in simulated eyes. 
We conclude that AO is an inexpensive yet equally effective alternative to the TDO in detecting red 
reflexes and due to its low cost, portability and consumable independence is well suited for use in 














Reduction of childhood blindness is a World Health Organisation priority (1). Although the 
prevalence of childhood blindness is estimated to be ten times lower than in adults, the number of 
disability-adjusted life years is greater with up to one-half of childhood blindness being preventable 
or treatable (1). Early diagnosis offers the best opportunity for effective prevention and treatment 
(2, 3). 
The red reflex (RR) test is a simple yet highly sensitive means to detect the majority of visually 
impairing conditions of childhood including corneal scaring, cataract and retinoblastoma but also 
refractive error, anisometropia and strabismus (4-6).  In regions where systematic screening for 
childhood eye disease is limited the RR test can be used opportunistically by a range of primary and 
mid-level health care workers to detect otherwise cryptic disease for early treatment and better 
outcomes (7, 8). 
The RR test can be easily performed with minimal training using a direct ophthalmoscope. The 
traditional direct ophthalmoscope (TDO) is however rarely available outside of specialist eye units in 
low and middle-income countries (LMICs). They are typically expensive and difficult to maintain in 
working order as they depend upon a supply of costly and hard to find bulbs and batteries (9). These 
limitations make the TDO largely inaccessible to most primary and mid-level healthcare workers in 
LMICs where the majority of childhood blindness is found. To address the limitations of the TDO the 
‘Arclight’ direct ophthalmoscope (AO) (9) has been developed. 
The AO is a low cost, consumable independent solar-powered ophthalmoscope that has been 
developed specifically to meet the needs of health care workers in LMICs (9). The AO utilises a light 
emitting diode (LED) with an integrated photovoltaic solar panel charging a slim internal 
rechargeable battery. Simplification of the design by placing the LED on the front of the device below 
the sight hole has allowed miniaturisation (110 mm long x 26 mm wide x 9 mm thick, 18g) making it 
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easily portable (Figure 1). In addition to functioning as a direct ophthalmoscope the AO has an 
integrated magnifying loupe which can also function as an otoscope. Importantly when sold in bulk it 
can be purchased for £10 per unit. Initial evaluation studies have shown the device to be at least as 
effective as a traditional device and perceived as easier to use (10 -13). 
The AO consequently offers the opportunity to expand direct ophthalmoscopy access in low 
resource settings and increase RR assessments amongst young children reducing the burden of 
needless blindness and death. No study has however yet evaluated the specificity and sensitivity of 
the AO when in the RR test compared to a TDO. This study therefore aims to compare the AO with a 
TDO in assessing the findings of the RR test on simulated eyes when used by health care workers in 
Malawi.  
METHOD 
The study was conducted at the Kamuzu Central Hospital Campus in Lilongwe, Malawi. 19 optometry 
students from the School of Optometry and 17 paediatric doctors from the Paediatric Department of 
were recruited.  
A short presentation was given outlining the study including the findings of normal and abnormal RR 
tests on the simulation eyes. Participants then examined eight simulation eyes containing four 
abnormal and four normal red reflexes. There were 4 possible red reflex abnormalities designed to 
mimic specific pathologies (Figure 2): White reflex (retinoblastoma), central dark opacity (polar 
cataract), peripheral wedge shaped opacity (cortical cataract) and a misshapen pupil (coloboma). 
The order of the eight simulated eyes examined and the initial device used were chosen using a 
random number generator. Once every simulated eye in the first run was examined and findings 
documented the same simulated eyes were rearranged into a different random order. The 
participant then examined a second array of 8 simulated eyes with the other device. After examining 
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the simulation eyes the participants recorded an ease of use score for both devices using a Likert 
Scale with 1 being “very easy to use” and 5 being “very hard to use”.  
Data analysis 
Data were entered into a spread sheet and analysed using IBM SPSS Statistics for Windows, Version 
22. All tests were two tailed with type I error set at α = 0.05. Paired t-test was used to analyse the 
paired parametric data from each participant. Ordinal data from Likert Scale scores for the two 
devices were compared using Wilcoxon Signed-Rank test. Specificity, sensitivity, positive and 
negative predictive values were calculated for each device and the paired outcomes were compared 
using McNemar’s test. 
Ethical Approval 
Ethical approval was given from the University of Leeds, University of St Andrews and the College of 
Medicine Research and Ethics Committee, Malawi. 
RESULTS 
Diagnostic performance 
The ability to identify abnormal RR tests was comparable between the two devices (Table 1) with the 
mean score for correct diagnosis 6.78 out of 8 for the TDO and 6.53 out of 8 for the AO. The 
difference was not statistically significant (p = 0.203).   The breakdown of the results showed that 
the optometry students demonstrated a trend to better diagnostic skills with both devices compared 






Table 1: Healthcare professional's scores using the two devices  
  
Mean diagnostic score out of a 
mximum of 8 
p-value 
 AO TDO  
Doctors & Optometrists 6.53 6.78 p = 0.203 
    
Device Doctors Optometrists   
AO 6.35 6.68 p = 0.587 
TDO 6.52 7 p = 0.460 
AO + TDO 6.44 6.84 p = 0.355 
 
As expected the differences in sensitivity, specificity, positive and negative predictive values of AO 
and TDO in detecting pathology in simulated eyes were also not statistically significant (Table 2). 
However, the AO had a trend to be slightly better on sensitivity and the TDO on specificity. 
Importantly, the negative predictive values of both devices were well above 80%. 
Table 2: Diagnostic performance of the two devices  
   AO (95% CI) TDO (95% CI) 
Sensitivity 85.4% (79.7% - 91.2%) 83.5% (77.2% - 89.4%) 
Specificity 77.8% (71.0% - 84.6%) 86.1% (80.4% - 91.8%) 
Positive predictive value 79.4% (73.0% - 85.7%) 85.7% (79.0% - 91.5%) 
Negative predictive value 84.2% (78.0% -90.4%) 83.7% (77.8% - 89.7%) 
McNemar’s Test showed the difference in the proportions listed above between the 
two devices were statistically insignificant, p-value = 0.211 
 
No learned effect was observed as there was no statistically significant difference between the 
average correct score for the first and second rounds (6.66 vs 6.63 respectively p-value = 0.95).  
Ease of Use 
Overall there was a non-statistically significant (p = 0.64) trend for ease of use in favour of the AO 
with median Likert Scale score of 1 for the AO compared to 2 for the TDO. 20 participants (over half) 
ranked the AO as ‘very easy to use’ while only 11 (just under a third of participants) considered the 
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TDO at this level. One participant ranked the AO as ‘very hard to use’ while three participants ranked 
the TDO at this level.  
DISCUSSION 
Most direct ophthalmoscopes are designed for users working in developed regions of the world; 
they are typically expensive, dependent on often hard to find consumables and are increasingly 
unnecessarily complex. As a consequence, TDOs are rarely available in low income health care 
systems and even if they are present they are often in a non-functional state like many other 
medical devices found in hospitals of resource poor regions (14). The AO has been specifically 
designed to address the barriers to access of TDOs in LMICs. This study has shown that it has an 
equivalent diagnostic performance in identifying abnormal red reflex appearances in simulated eyes 
compared to a TDO amongst Malawian healthcare workers. Despite its low cost and simple design, 
the AO was preferred by the majority of study participants and was considered just as easy to use. 
We have shown that the AO is an effective diagnostic tool amongst health care workers in Malawi 
where the additional features of being low-cost, consumable independent, extremely portable, 
compact and rugged are especially pertinent. These features make the AO an ideal frugal yet 
effective device for LMICs as recommended by both the Vision 2020 initiative and the Lancet 
Commission on Technologies for global health (15, 16). The findings of this study are supported by 
others. Blundell and colleagues demonstrated that the AO is as effective as the TDO in diagnosing 
diabetic retinopathy in a simulated eye study (11) amongst health care workers also in Malawi, and 
Moin et al replicated these results on human subjects in Pakistan (12). In Tanzania, Lowe et al 
showed that the AO performs as well as the TDO in assessing the appearance of the optic nerve in 
human subjects (10).  Additionally, in both these two studies the participants rated the AO as easier 
of use. This may reflect the simplified, intuitive design and avoidance of ‘feature creep’ which afflicts 
and limits the usability of many medical devices (16). 
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Furthermore, unlike telemedicine approaches that use more expensive dedicated retinal or mobile 
phone camera devices (17), the AO empowers healthcare workers to make independent on the spot 
diagnoses strengthening the human resource and thus further satisfying the three pillars of the 
Vision 2020 initiative (18).  
The main limitation of this study is that a simulation eye does not adequately replicate the 
examination of a young and potentially uncooperative child. Therefore now that this initial study has 
been performed further studies should evaluate the device in assessing the RR in real patients and in 
particular babies. 
In view of the growing positive evidence base (9-13) the International Association of Prevention of 
Blindness (IAPB) has endorsed the Arclight by including it on the ‘Standard List’ of recommended 
device for use in LMICs with over 10,000 devices currently in use around the world (19).  Our study 
adds further evidence that adoption of the Arclight by health care systems in LMICs can assist in the 
diagnosis of eye disease reducing needless blindness in these regions where the burden is greatest 
yet access to diagnostic devices least. 
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Arclight ophthalmoscope: Design simplification include LED placed on the front of device just below 
the sight hole 
 
Figure 2 
Title: Normal and abnormal red reflexes in simulation eyes  
Legend: a) Participant examining the simulation eye, b) normal red reflex, c) white reflex 
(retinoblastoma), d) central dark opacity (posterior polar cataract), e) a misshapen pupil (coloboma), 
and f) peripheral wedge shaped opacity (lamellar cataract). 
